tm logo
NK VUE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 04 Feb 2023

Last Applicant/ Owned by

SNUH HIP 6F, 172 DOLMA-RO, BUNDANG-GU

SEONGNAM-SI, GYEONGGI-DO

KR

13605

Serial Number

86300720 filed on 04th Jun 2014

Registration Number

4993881 registered on 05th Jul 2016

in the Principal Register

Correspondent Address

Margaret C. McHugh

Margaret C. McHugh

Two Embarcadero Center, Suite 1900

San Francisco CA 94111

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NK VUE

diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations f Read More

Classification Information


Class [001]
Chemical Products


NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use


First Use Date in General

31st Mar 2015

First Use Date in Commerce

31st Mar 2015

Class [005]
Pharmaceutical Products


diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use


First Use Date in General

31st Mar 2015

First Use Date in Commerce

31st Mar 2015

Specimens


NK VUE specimenNK VUE specimen

Mark Details


Serial Number

No 86300720

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 97060-910631

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Feb 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04th Feb 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04th Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03rd Aug 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
19th Jul 2022TEAS SECTION 8 & 15 RECEIVED
05th Jul 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02th Dec 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
05th Jul 2016REGISTERED-PRINCIPAL REGISTER
02th Jun 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01st Jun 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED